Member Info for ontarget

Indeed, I doubt serious ii's and fund managers have invested multi-millions in this because it's 'snake oil'.

https://evgen.com/investors/shareholder-information/

Big increase, bearing in mind the extra shares in issue.

Note I converted LBPS volume into equivalent in DDDD shares i.e. x8 etc.

Today's volume LBPS £138k
Today's volume DDDD £2.8M
So why is a market with currently 1/20th of the volume controlling the DDDD shareprice?!

You've drawn a sloping-down line on the chart and have picked an arbitrary point (time) on that line for your 'support price'. If you look closely at your line you'll notice that over time it eventually reaches 0 and proceeds below the x-axis.
I think you urgently need to buy 'charting for dummies'. It might tell you what a 'gap' is as well since you weren't sure on the Lloyds thread.

"Astronomical growth"

Impressive interview.

Looks like the market has decided this company is a total failure and it should be priced accordingly. With (a conservative) 4p/share in cash, the Juvenescence deal with its $10.5m milestones plus royalties, the phase 2 breast cancer results, the risked value of ARDS/COVID trial and all the pre-clinical prospects in their various stages, other IP, patents etc. - the sum total value of all of this according to the market, even with the funding behind them, is a whole.. £8m. Absolute joke.

How can they sell LOAC shares now without converting to LBPS? LOAC doesn't exist anymore does it?

Looks more like they're finishing off the last of the seller and will now want to take it up, to me.
Doesn't look like it wants to go below 0.10-0.11.

My LOAC holding in my dealing account has now been changed to a '4D PHARMA ADR' holding with 0 value that can't be bought nor sold. I assume this will soon change to a LBPS holding? Anyone else had this?

Looks like the broker's starting to put in some leg work at last.

Excellent article JSB, thanks for posting. First time I've seen Daily Mail cover this stock.

How's your 6p buy order doing btw Kingalf?

Driven up? What do you mean Sangjulas this is the same price it was 3 years ago?! When was the pump?

If that really is the case about US investors being worried, Sangiulas (despite it not being reflected in the market), then which biotech company are they going to buy, the ones wildly overvalued, or DDDD/LBPS?

I see, so you're not giving an opinion based on justifications (hence the complete lack of any), you're simply telling us a fact based on your observation in the future (you being a benevolent time traveller come to warn us of losing our money). About right?

radar,

Can you remind us what exactly your 'beef' is here, is there something about EVG you don't like? Or do you just enjoy going onto share threads and winding up holders?

Have you noticed the MMS are almost never on the bid/offer? So you think they’re not doing any business? No of course not, half the book orders are from the MMs.

Patronising idiot.

Errr nope. Each LBPS is worth 8 4D shares - have a look at Wigscoff post earlier, he sums it up well.